Literature DB >> 24021672

Blood consult: paroxysmal nocturnal hemoglobinuria and its complications.

Danielle M Townsley1, Neal S Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24021672      PMCID: PMC3798994          DOI: 10.1182/blood-2013-07-360081

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

1.  Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes: clonal expansion of PIG-A-mutant hematopoietic cells in bone marrow failure.

Authors:  Neal S Young
Journal:  Haematologica       Date:  2009-01       Impact factor: 9.941

Review 2.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Charles J Parker
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

3.  Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

Authors:  J P Maciejewski; D Follmann; R Nakamura; Y Saunthararajah; C E Rivera; T Simonis; K E Brown; J A Barrett; N S Young
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

4.  Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.

Authors:  Régis Peffault de Latour; Hubert Schrezenmeier; Andrea Bacigalupo; Didier Blaise; Carmino A de Souza; Stephane Vigouroux; Roelf Willemze; Louis Terriou; Andre Tichelli; Mohamad Mohty; Sophie de Guibert; Judith C Marsh; Jakob Passweg; Jean Yves Mary; Gerard Socié
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

5.  Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria.

Authors:  A Karadimitris; J S Manavalan; H T Thaler; R Notaro; D J Araten; K Nafa; I A Roberts; M E Weksler; L Luzzatto
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

6.  The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab.

Authors:  Richard Kelly; Louise Arnold; Stephen Richards; Anita Hill; Charlotte Bomken; John Hanley; Andrew Loughney; Jon Beauchamp; Gus Khursigara; Russell P Rother; Elizabeth Chalmers; Andrew Fyfe; Edward Fitzsimons; Ryotaro Nakamura; Anna Gaya; Antonio M Risitano; Jörg Schubert; Derek Norfolk; Nigel Simpson; Peter Hillmen
Journal:  Br J Haematol       Date:  2010-02-11       Impact factor: 6.998

7.  Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.

Authors:  Antonio M Risitano; Rosario Notaro; Ludovica Marando; Bianca Serio; Danilo Ranaldi; Elisa Seneca; Patrizia Ricci; Fiorella Alfinito; Andrea Camera; Giacomo Gianfaldoni; Angela Amendola; Carla Boschetti; Eros Di Bona; Giorgio Fratellanza; Filippo Barbano; Francesco Rodeghiero; Alberto Zanella; Anna Paola Iori; Carmine Selleri; Lucio Luzzatto; Bruno Rotoli
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 8.  Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.

Authors:  Antonio M Risitano
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

9.  A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement.

Authors:  Margaret A Lindorfer; Andrew W Pawluczkowycz; Elizabeth M Peek; Kimberly Hickman; Ronald P Taylor; Charles J Parker
Journal:  Blood       Date:  2010-01-12       Impact factor: 22.113

10.  Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky; Neal S Young; Elisabetta Antonioli; Antonio M Risitano; Hubert Schrezenmeier; Jörg Schubert; Anna Gaya; Luke Coyle; Carlos de Castro; Chieh-Lin Fu; Jaroslaw P Maciejewski; Monica Bessler; Henk-André Kroon; Russell P Rother; Peter Hillmen
Journal:  Blood       Date:  2007-11-30       Impact factor: 22.113

View more
  4 in total

Review 1.  Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.

Authors:  Amy E DeZern; Robert A Brodsky
Journal:  Hematol Oncol Clin North Am       Date:  2015-03-07       Impact factor: 3.722

2.  Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis.

Authors:  Ruby Sharma; Alla Keyzner; Johnson Liu; Thomas Bradley; Steven L Allen
Journal:  Leuk Res Rep       Date:  2015-05-16

Review 3.  Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations.

Authors:  Fatimah Al-Ani; Ian Chin-Yee; Alejandro Lazo-Langner
Journal:  Ther Clin Risk Manag       Date:  2016-08-01       Impact factor: 2.423

4.  Interaction between Herpes Virus Infections and IL10 and Risk of Bone Marrow Suppression.

Authors:  R Yaghobi; F Alizadeh; A Khodavandi
Journal:  Int J Organ Transplant Med       Date:  2018-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.